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Chapter 8
In the present thesis, interaction of the human plasma factor 100KF with the
glomerular filtration barrier of the rat kidney was studied using both kidney
perfusion ex vivo as well as direct renal perfusion in vivo.
The rationale of this investigation comes from clinical observations in patients
with primary nephrotic syndrome, showing glomerular proteinuria without
cellular infiltration or glomerular immune deposits. The pathogenesis nor the
etiology of this Minimal Change Nephrotic Syndrome (also called Minimal
Change Disease, MCD) is completely obscurer-4.
Despite lack of histological signs of immune system involvement, several
lines of evidence implicate immune mechanisms and/or circulating factors in
the pathogenesis of this nephropathyt-''. It is not known whether circulating
factors may be responsible for the ultrastructural and immuno-histochemical
alterations obserued in biopsies from subjects with MCD and related disorders
like focal segmental glomerulosclerosis (FSGS)r2. The involvement of
systemic factors in FSGS has recently gained renewed attention in particular
in subjects with recurrent FSGS, following kidney transplantationra'r5.
In the present study, experiments were designed to mimick the MCD-like
lesions in the experimental animal, using a vasoactive human circulating
plasma protease, called 100KFt6. It has been demonstrated in previous
experiments, that l00KF is able to affect human kidney tissue in vitro,
resulting in MCD-like alterations i.e. loss of glomerular polyanion (GPA) and
reduced expression of glomerular ecto-ATPaserT'r8. Except for the
histochemical alterations, the experimental set up described in these studies
allowed us also to investigate the pathophysiological aspects of enhanced
glomerular permeability induced by 100KF, leading to urinairy protein
excretion.
In the first study experiments were carried out to explore the effect of l00KF
in an isolated perfusion system of the rat kidney ex vivo. It was shown that
contact of the glomerular capillary wall with 100KF resulted in enhanced
(selective) glomerular permeability for plasma proteins associated with MCD-
like glomerular histochemical alterations [chapter 2].
In the next set of experiments, alterations of endothelial monolayers following
interaction with 100KF in vitro was studied [chapter 31. Both
histochemically detectable changes as well as the permeability of the
endothelial monolayer for a macromolecular marker (HRP) were investigated.
































































This was carried out using confluent HUVEC, cultured upon the filter within
a two-compartment culture system. It appeared that a significant dose-
dependent enhancement of permeability for HRP occurred following contact
of 100KF with the monolayer, whereas concomitant loss of extracellular
matrix molecules like sialoglycoproteins or ecto-ATPase upon the
endothelium could be detected. In contrast, heat-inactivated l00KF (control
factor) could not induce these effects. Similar loss of sialoglycoproteins and
reduced expression of endothelial ecto-ATPase could also be shown in
cultures of human glomerular endothelial cells (kindly provided by Drs P.A.
van Setten, Nijmegen, The Netherlands; see chapter 7).
At the ultrastructural level subendothelial sites of the glomerular capillary
wall of the rat kidney were studied after perfusion of 100KF or control factor
ex vivo. Using a cationic marker (PEI-1800), a reduced number of anionic
sites could be shown exclusively along the lamina rara intema (Lzu)
following perfusion with native 100KF, in contrast to control factor, again
suggesting that in particular endothelial and subendothelial sites may be
considered as target structures for l0OKF-mediated injury. Interestingly, in
biopsies from patients with MCD in relapse, similar loss of anionic sites has
been described exclusively at the LRI using identical cationic probes at the
ultrastructural evela.
In chapter 4, the expression of glomerular ecto-ATPase in normal human
kidney tissue as well as in biopsies derived from various groups of patients
(membranous glomerulopathy, IgA nephropathy, MCD, FSGS) was evaluated
using a polyclonal anti-ATPase antibody. The results clearly show a relative
decrease of glomerular ecto-ATPase expression in kidney tissue from subjects
with MCD and FSGS, in contrast to the other forms of glomerulopathy
included in this study, or to control human kidney tissue. As glomerular ecto-
ATPase is a sensitive marker molecule for oxidant injuryre, the question
emerges whether glomerular injury reflected by diminished expression of
glomerular ecto-ATPase in patients with MCD or FSGS, might be caused by
local oxidant stress, for instance induced by circulating 100KF.
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Chapter 8
Potential involvement of reactive oxygen species in l00KF-mediated injury is
described in chapter 5. In this study 100KF injury towards glomerular
extracellular matrix molecules was tested for oxygen dependency. As
affection of glomerular ecto-ATPase by l00KF can be shown to be prevented
by omission of oxygen in the microenvironment in vitro, whereas the
increased albumin leakage following perfusion with 100KF can be reduced by
addition of scavengers of oxygen free radicals, we conclude that in l00KF-
mediated injury, reactive oxygen species may play an active role. In contrast,
loss of GPA mediated by 100KF appears to be oxygen independent.
To examine potential lO0KF-mediated injury in vivo, experiments were
conducted in the rat equipped with a perïnanent cannula inserted into the
suprarenal artery (SRA) under conscious conditions. Direct infusion of 100K-F
into the microvasculature of the rat kidney showed a transient but significant
proteinuria, whereas during the active phase of increased urinary protein
excretion, reduced expression of glomerular ecto-ATPase, loss of
subendothelial anionic sites as well as podocyte fusion was observed.
The ability of l00KF to induce proteinuria in vivo was confirmed by a
second in vivo model in anaesthetized animals. In this set of experiments, the
urine production of both kidneys was monitored; thus, urine samples were
collected from the kidney perfused with either l00KF or control factor, as
well as from the non-perfused (control) kidney. Although significant peaking
of proteinuria following 100KF infusion is again transient, lasting
approximately for one hour, significantly enhanced protein excretion remains
during the entire observation period, i.e. the next four hours. It is concluded
that 100KF is able to induce transient proteinuria, in association with
characteristic MCD-like alterations in the rat kidney [chapter 6].
In the next study alterations of human glomerular endothelium in vitro
following incubation with 100KF or control factor are described. These cell
cultures were kindly provided by Drs P.A. van Setten (Department of
Pediatric Nephrology, Head: Prof. Dr L.A.H. Monnens, St. Radboud Hospital
Nijmegen, The Netherlands). In this investigation the expression of HSPG
core protein as well as HSPG side chain was studied by immuno staining of
the rat kidney foliowing perfusion with either native 100KF or heat-
inactivated control factor. Monoclonal antibodies recognizing HSPG side
chain as well as polyclonal antibodies directed against core protein were
kindly provided by Dr. J. van den Bom, Department of Nephrology (Head:





































































The results show a significant reduced expression of side chain in kidneys
perfused with l00KF, in contrast to HSPG core protein, which was shown to
be uneffected. Loss of extracellular matrix molecules following incubation of
human glomerular endothelial cell cultures could be achieved after incubation
with active 100KF, in contrast to incubation with heat-inactivated control
factor. This is in line with results obtained in HUVEC, supporting the
concept that glomerular endothelial and subendothelial areas may be
considered as potential target sites for 100KF induced tissue damage, leading
to enhanced glomerular permeability [chapter 7].
100KF and other plasma factors in nephrotic syndrome
The observations described in this thesis allow the conclusion that in normal
human semm a factor occurs which is able to mimic characteristic glomerular
MCD-like alterations in the rat kidney following contact with the renal
microcirculation, leading to increased permeability of the glomerular filtration
barrier for plasma proteins. The factor, denoted as 100KF, differs from other
plasma factors recently described in the literature, with respect to several
physico-chemical properties. Table I shows some major characteristics of
100KF. The plasma constituent described by Savin et al ta, which can be
found in plasma from nephrotic subjects with FSGS, showed enhanced
glomerular permeability for plasma proteins as tested in vitro with isolated rat
glomeruli2o. However, serum samples from nephrotic subjects with
corticosteroid sensitive MCD did not show enhanced glomerular permeability
in their test system (personal communication), suggesting that possibly
separate permeability factors may occur in the respective disorders. The
glomerular permeability increasing factor described by Garin et al 2t'22, is
probably related (or identical) to interleukine-8, since antibodies directed to
this cytokines were able to abolish its proteinuria inducing effect. The plasma
factor recently described by Dantal et al ts, which was found in subjects with
recurrent FSGS following kidney transplantation appeared to bind with
protein-A in contrast to 100KF. (Some controversy is emerging as to the
reproducability of the latter plasma factor). Unlike 100KF, none of these




Tabel 1. Characteristics of I00KF
molecular mass : 80-100 kDaltons glycoprotein
iso-electrical point: 6.I
inactivation : 30 min. at 75oC
errzymatic activity: * serine protease (kallikreine-like according to
amidolytic assay)
* inhibitable by PMSF
synthesis : hepatocytes
miscellaneous ' * vasoactive
properties * enhances Con-A activated blast transformation
of peripheral mononuclear blood cells in vitro in
a dose-dependent manner
* enhances 02'release in neutrophil granulocytes
in vitro.
Initiation of 100KF activity
Assuming that 100KF and/or other circulating factors, present in normal
human serum in an inactive form, are able to play a role in the pathogenesis
of proteinuria, the question as to the conversion of these factors into
nephrotodc agent can be raised. As certain clinical events frequently precede
relapsing of MCD, i.e. upper respiratory infections23'z{ or type I allergic
reactions zs'26, it is likely that an immunologic stimulus is involved in the
activation of the putative factor. Involvement of immunological mechanisms
in MCD is also supported by the fact that immunosuppressants like
cyclophosphamide or cyclosporin A, as well as corticosteroids are able to
induce remission in MCD27. Many enzymes are synthetized as inactive
eÍtzyme precursors (zymogens), which can be activated by cleavage of
specific peptide bonds. Proteolytic activation occurs for instance in proteins
of the blood coagulation system leading to active clotting factors, many of
which are sèrine proteases2s. Similar zymogenic activations occur in serine
proteases of the complement system2e.
r20
General discussion
It is conceivable that cellular immune reactivity, producing cytokines like for
instance TNFa, which can prime inflammatory cells as well as activate
clotting proteins30, are involved in local activation of circulating l00KF.
However, the occurrence of inactive enzymes may also be due to other
mechanisms such as enzyme inhibitors complexed to the active enzyme, as
suggested by Thomson and Kraft3r. These authors speculate that dissociation
of the putative inhibitor from the protein:inhibitor complex may activate a
MCD-associated plasma factor. Dissociation of inhibitors from protein
complexes should be detectable in electrophoretic pattems of plasma fractions
from nephrotic patiens versus control subjects. Although such differences
were not detected up to now, further meticulous analysis using gradient gel
electrophoresis (PAGE) under native and reduced conditions may shed light
on this issue.
The nature of 100KF
One of the most obvious questions deals with the biochemical identity of
100KF. However except for some vascular permeability factors described in
the literature32, the nature of vascular permeability enhancing plasma
constituents which seem relevant in nephrotic syndrome are not at all, or
poorly characteriz.6s'33-3s. This situation is probably due to the elusive
character of such plasma constituents. Indeed, vigorous purification
procedures frequently result in loss of the characteristic properties of such
factors including l00KF. Nevertheless, it seems relevant to try and elucidate
the active principle of 100KF. To test this, internal sequence analysis was
performed (itt cooperation with Dr H. Bak and Dr W.J. Weijer,
Eurosequence, Science Park Groningen, The Netherlands) following SDS-
PAGE, trypsin digestion and preparative HPLC. Determination of 12
aminoacids in 2 separate chains (in the gradient PAGE gel approximately 80
kDa, which was recognized by polyclonal anti-lO0KF antibodies) revealed
homology with the human plasma protein hemopexin (frg. 1).
Affinity chromatography using polyclonal (rabbit-)anti-hemopexin antibody
(Dako) was able to bind the active component of l00KF, whereas also
immuno-blotting studies showed immunologic similarity of 100KF and
hemopexin. On the other hand, no protease-like activity or oxidase-like
activity has been described in hemopexin as such, or in associated molecules
like hemopexin binding protein36-38.
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Chapter 8
1 IATPL PPTSA HGNVA EGETK PDPDV TERCS DGWSF DATTL DDNGT MLFFK
5I GEFVW KSHKW DRELI SERWK NFPSP VDAAF RQGHN SVFLI KGDKV WVYPP
IOI EKKEK GYPKL LQDEF PGIPS PLDAA VECHR GECQA EGVLF FQGDR EWFWD
I5I LATGT MKERS WPAVG NCSSA LRWLG RYYCF QGNQF LRFDP VRGEV PPRYP
201 RDVRD YFMPC PCRGH GHRNG TGHGN STHHG PEYMR CSPHL VLSAL TSDNH
251 GATYA FSGTH YWRLD TSRDG WHSWP IAHQW PQGPS AVDAA FSWEE KLYLV
301 QGTQV YVFLT KGGYT LVSGY PKRLE KEVGT PHGII LDSVD AAFIC PGSSR
351 LHIMA GRRLW WLDLK SGAQA TWTEL SWPHE KVDGA LCMEK SLGPN SCSAN
401 GPGLY LIHGP NLYCY SDVEK LNAAK ALPQP QNVTS LLGCT H
Figure l. Amino acids sequence of human hemopexin. The standard one-letter code for
aminoacids is used. Homologous qminoacids as determined in 100KF fraction were
underlined.
Whereas the molecular weight of hemopexin per se seems smaller
(approximately 63 kDa3e), complex-formation (for instance haem:hemopexin
binding protein36), as well as the occuÍrence of hemopexin-like domains in
metallo-proteinases uch as type IV collagenase (gelatinase; Mw 72 kDa40'4r)
have been described. Whether the hemopexin moiety in 100KF has to be
considered as a domain of such an enzyme, or rather as a special form of free
hemopexin remains to be investigated.
Biochemical analyses, including zymographic techniques, in cooperation with
Dr P. van Koolwijk (Gaubius Institute, Leiden, The Netherlands) have
confirmed the presence of kallikrein-like protease activity in 100KF. Also
smaller fragments (20-30 kDa) showed protease activity using homogenous
polyacrylamide gel and SDS, supplemented with caseine or gelatine. Until
now, a possible relationship of these enzymatic activities with hemopexin is
unknown.
The picture emerging so far from aminoacid sequence, dot blot, and column
chromotography studies may point to a complexed hemopexin molecule
showing protease activity rather than a proteinase with a hemopexin-like
domain. Hopefully well-characterized purified fragments with 100KF activity
will become available in the near future, against which monoclonal antibodies
can be prepared, enabling systemic analysis of the lO0KF-status in nephrotic
patients.
Whatever the outcome of fuither molecular biological analysis will be, it is
clear that elucidation of the nature and pathophysiological activity of this
intriguing plasma constituent may increase our understanding of the barrier
function of the glomerular filter in health and disease.
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